| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.29 | 5e-16 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-14 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-13 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-12 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.25 | 1e-12 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-12 |